Macrogenics (MGNX) Return on Sales (2012 - 2026)

Macrogenics (MGNX) posted quarterly Return on Sales of 0.02% for Q1 2026, up 1.0% year-over-year from 0.02% in Q1 2025, and down 446.55% quarter-over-quarter from 0.0% in Q4 2025.

Macrogenics (MGNX) Return on Sales (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Return on Sales for 15 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Sales eased to 0.02% in Q1 2026 per MGNX's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.01% in Q3 2024 and bottomed at 0.11% in Q1 2024.
  • Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.02% in 2026.
  • Annual changes were most pronounced in 2022 — Return on Sales grew 27 bps — and 2024, when it dropped 9 bps.
  • Macrogenics' Return on Sales stood at 0.0% in 2022, then slumped by 2908 bps to 0.05% in 2023, then soared by 92 bps to 0.0% in 2024, then rose by 11 bps to 0.0% in 2025, then plunged by 447 bps to 0.02% in 2026.
  • Business Quant data shows MGNX's Return on Sales at 0.02% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Macrogenics 268.22 Mn 201.71 Mn - -0.02%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.02%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 -0.02%
Mar 31, 2025 -0.03%
Dec 31, 2024 0.00%
Sep 30, 2024 0.01%
Jun 30, 2024 -0.05%
Mar 31, 2024 -0.11%
Dec 31, 2023 -0.05%
Sep 30, 2023 -0.03%
Jun 30, 2023 -0.04%
Mar 31, 2023 -0.02%
Dec 31, 2022 0.00%
Sep 30, 2022 -0.01%
Jun 30, 2022 -0.02%
Mar 31, 2022 -0.06%
Dec 31, 2021 -0.27%
Sep 30, 2021 -0.05%
Jun 30, 2021 -0.03%